SCHEMBL129252

SCHEMBL129252

CC([O])C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1240634 0.97 SHBG (0.43)
SCHEMBL20594181 0.97 SHBG (0.43)
SCHEMBL20594356 0.97 SHBG (0.43)
SCHEMBL21469 0.97
SCHEMBL6673265 0.97 SHBG (0.43)
SCHEMBL126871 0.93
SCHEMBL28332 0.86
SCHEMBL8010131 0.78 SHBG (0.38)
SCHEMBL7840128 0.75 CPN1 (0.41)
SCHEMBL8009630 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 873 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112898286-A Benzothiophene compound or pharmaceutically acceptable salt and isomer thereof, and preparation method, pharmaceutical composition and application thereof 中国药科大学 2021-06-04 CN claimed
CN-105085429-B Aromatic heterocyclic derivative and application thereof in medicines 广东东阳光药业有限公司 2019-12-10 CN claimed
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO claimed
WO-2015161830-A1 HETEROAROMATIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-10-29 WO claimed
EP-1852420-B1 Indole compounds for treating respiratory disorders ONO PHARMACEUTICAL CO (JP) 2012-10-17 EP claimed
US-20110077234-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2011-03-31 US claimed
US-7884210-B2 {2-[3-(2-Cyclohex-1-enyl-ethyl)-3-(trans-4-methyl-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid; for treatment of type 2 diabetes NOVO NORDISK A/S (DK) 2011-02-08 US claimed
US-20090105482-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2009-04-23 US claimed
JP-2009501198-A 2009-01-15 JP claimed
EP-1904467-A1 UREA GLUCOKINASE ACTIVATORS Novo Nordisk A/S (DK) 2008-04-02 EP claimed
WO-2007006814-A1 UREA GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2007-01-18 WO claimed
US-4348393-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1982-09-07 US claimed
CN-112279864-B Difunctional coumarin oxime ester compound and preparation and application thereof 湖北固润科技股份有限公司 2024-07-16 CN disclosed
EP-4396173-A1 HERBICIDAL MALONAMIDES CONTAINING A CONDENSED RING SYSTEM BASF SE (DE) 2024-07-10 EP disclosed
EP-4396163-A1 HERBICIDAL MALONAMIDES CONTAINING MONOCYCLIC HETEROAROMATIC RINGS BASF SE (DE) 2024-07-10 EP disclosed
WO-2024137629-A1 AZOLE COMPOUNDS FOR CONTROLLING AND COMBATING INVERTEBRATE PESTS FMC CORPORATION (US) 2024-06-27 WO disclosed
US-4526786-A N-Substituted phenyl-5-aminomethyl oxazolidinones and their method of use DELALANDE S.A. (FR) 1985-07-02 US disclosed
US-4435415-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1984-03-06 US disclosed
US-4348393-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1982-09-07 US disclosed
US-4287351-A USEFUL AS ANTIDEPRESSANTS DELALANDE S.A. (FR) 1981-09-01 US disclosed